TYPE-2 NEUROFIBROMATOSIS - THE NEED FOR SUPRAREGIONAL CARE

被引:42
|
作者
EVANS, DGR
RAMSDEN, R
HUSON, SM
HARRIS, R
LYE, R
KING, TT
机构
[1] MANCHESTER ROYAL INFIRM, DEPT OTOLARYNGOL, MANCHESTER M13 9WL, LANCS, ENGLAND
[2] CHURCHILL HOSP, DEPT MED GENET, OXFORD OX3 7LJ, ENGLAND
[3] MANCHESTER ROYAL INFIRM, DEPT NEUROSURG, MANCHESTER M13 9WL, LANCS, ENGLAND
[4] LONDON HOSP, DEPT NEUROSURG, LONDON E1 1BB, ENGLAND
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 1993年 / 107卷 / 05期
关键词
NEUROFIBROMATOSIS; CENTRAL; NF2;
D O I
10.1017/S002221510012328X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The results of a U.K. study of 145 cases of type 2 neurofibromatosis has shown generally very poor operative results in terms of hearing and facial nerve preservation. Only 9 out of 118 vestibular schwannoma (acoustic neuroma) operations resulted in any clinically detectable hearing preservation and only 32 left the patient with good or normal (House grade I or II) ipsilateral facial nerve function. Although operation is still the definitive treatment of vestibular schwannoma (acoustic neuroma) and may be a lifesaving procedure, it appears that the evidence in favour of early operation is only valid when carried out in highly specialized centres. The special problems of NF2 cases who may go on to develop multiple spinal and cranial tumours making them wheelchair bound and blind as well as deaf warrants a careful experienced approach. Timing of operations may be critical for the enhancement of useful years of quality life. We therefore propose the setting up of a national NF2 register, with the management of cases at a few supraregional centres.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [21] EPITHELIOID SARCOMA ARISING IN A PATIENT WITH NEUROFIBROMATOSIS TYPE-2
    ROSE, DSC
    FISHER, C
    SMITH, MEF
    HISTOPATHOLOGY, 1994, 25 (04) : 379 - 380
  • [22] MIXED CRANIAL NERVE TUMORS IN NEUROFIBROMATOSIS TYPE-2
    GEDDES, JF
    SUTCLIFFE, JC
    KING, TT
    CLINICAL NEUROPATHOLOGY, 1995, 14 (06) : 310 - 313
  • [23] BILATERAL CEREBELLOPONTINE ANGLE TUMORS IN NEUROFIBROMATOSIS TYPE-2
    BALDWIN, D
    KING, TT
    CHEVRETTON, E
    MORRISON, AW
    JOURNAL OF NEUROSURGERY, 1991, 74 (06) : 910 - 915
  • [24] NEUROFIBROMATOSIS TYPE-2 APPEARS TO BE A GENETICALLY HOMOGENEOUS DISEASE
    NAROD, SA
    PARRY, DM
    PARBOOSINGH, J
    LENOIR, GM
    RUTTLEDGE, M
    FISCHER, G
    ELDRIDGE, R
    MARTUZA, RL
    FRONTALI, M
    HAINES, J
    GUSELLA, JF
    ROULEAU, GA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1992, 51 (03) : 486 - 496
  • [25] A CANDIDATE GENE FOR NEUROFIBROMATOSIS TYPE-2 (NF2)
    DREYFUS, JC
    M S-MEDECINE SCIENCES, 1993, 9 (04): : 484 - 484
  • [26] NEUROFIBROMATOSIS TYPE-2 PROTEIN COLOCALIZES WITH ELEMENTS OF THE CYTOSKELETON
    DENBAKKER, MA
    TASCILAR, M
    RIEGMAN, PHJ
    HEKMAN, ACP
    BOERSMA, W
    JANSSEN, PJA
    DEJONG, TAW
    HENDRIKS, W
    VANDERKWAST, TH
    ZWARTHOFF, EC
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (05): : 1339 - 1349
  • [27] CUTANEOUS PLEXIFORM SCHWANNOMA ASSOCIATED WITH NEUROFIBROMATOSIS TYPE-2
    VALBERNAL, JF
    FIGOLS, J
    VAZQUEZBARQUERO, A
    CANCER, 1995, 76 (07) : 1181 - 1186
  • [28] SPINAL MR FINDINGS IN NEUROFIBROMATOSIS TYPE-1 AND TYPE-2
    EGELHOFF, JC
    BATES, DJ
    ROSS, JS
    ROTHNER, AD
    COHEN, BH
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1992, 13 (04) : 1071 - 1077
  • [29] NEUROFIBROMATOSIS TYPE-1 AND TYPE-2 - CRANIAL MR FINDINGS
    AOKI, S
    BARKOVICH, AJ
    NISHIMURA, K
    KJOS, BO
    MACHIDA, T
    COGEN, P
    EDWARDS, M
    NORMAN, D
    RADIOLOGY, 1989, 172 (02) : 527 - 534
  • [30] IDENTICAL INACTIVATING MUTATION IN 3 CHILDREN WITH NEUROFIBROMATOSIS TYPE-2
    MACCOLLIN, M
    BRAVERMAN, N
    SIFFERT, J
    HOFMAN, K
    GUSELLA, J
    PARRY, D
    ANNALS OF NEUROLOGY, 1995, 38 (03) : 554 - 554